Fulgent Genetics (STU:7F0) Net Issuance of Preferred Stock : €0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Fulgent Genetics Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Fulgent Genetics's net issuance of preferred for the three months ended in Mar. 2025 was €0.0 Mil. The number is 0, which means that Fulgent Genetics has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Fulgent Genetics's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was €0.0 Mil.

Fulgent Genetics Net Issuance of Preferred Stock Historical Data

The historical data trend for Fulgent Genetics's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Net Issuance of Preferred Stock Chart

Fulgent Genetics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Fulgent Genetics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Fulgent Genetics Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Fulgent Genetics Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (STU:7F0) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

FLGT:USA FLGT:Mexico 7F0:Germany

Address

4399 Santa Anita Avenue, El Monte, CA, USA, 91731

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Headlines

No Headlines